EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma

Guanqiang Yan iD, Guosheng Li, Xiang Gao, Jun Liu, Yue Li, Jingxiao Li iD, Huafu Zhou iD

The Clinical Respiratory Journal · 2024-05 · 18 (5)

DOI: 10.1111/crj.13757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 07.05.2024. Verfasst von Guanqiang Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardio-Thoracic Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Biomarkers, Tumor, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Medical And Health Key Discipline Construction Project, Guangxi Key Clinical Specialty Construction Project, National Key Clinical Specialty Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This research was aimed to comprehensively investigate the expression levels, diagnostic and prognostic implications, and the relationship with immune infiltration of G2 and S phase‐expressed‐1 ( GTSE1 ) across 33 tumor types, including lung adenocarcinoma (LUAD), through gene expression profiling.

Methods

GTSE1 mRNA expression data together with clinical information were acquired from Xena database of The Cancer Genome Atlas (TCGA), ArrayExpress, and Gene Expression Omnibus (GEO) database for this study. The Wilcoxon rank‐sum test was used to detect differences in GTSE1 expression between groups. The ability of GTSE1 to accurately predict cancer status was evaluated by calculating the area under the curve (AUC) value for the receiver operating characteristic curve. Additionally, we investigated the predictive value of GTSE1 in individuals diagnosed with neoplasms using univariate Cox regression analysis as well as Kaplan–Meier curves. Furthermore, the correlation between GTSE1 expression and levels of immune infiltration was assessed by utilizing the Tumor Immune Estimate Resource (TIMER) database to calculate the Spearman rank correlation coefficient. Finally, the pan‐cancer analysis findings were validated by examining the association between GTSE1 expression and prognosis among patients with LUAD.

Results

GTSE1 exhibited significantly increased expression levels in a wide range of tumor tissues in contrast with normal tissues ( p < 0.05). The expression of GTSE1 in various tumors was associated with clinical features, overall survival, and disease‐specific survival ( p < 0.05). In immune infiltration analyses, a strong correlation of the level of immune infiltration with the expression of GTSE1 was observed. Furthermore, GTSE1 demonstrated good discriminative and diagnostic value for most tumors. Additional experiments confirmed the relationship between elevated GTSE1 expression and unfavorable prognosis in individuals diagnosed with LUAD. These findings indicated the crucial role of GTSE1 expression level in influencing the development and immune infiltration of different types of tumors.

Conclusions

GTSE1 might be a potential biomarker for the prognosis of pan‐cancer. Meanwhile, it represented a promising target for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungBiomarkers, TumorLung NeoplasmsFemaleHumansMaleMiddle AgedGene Expression ProfilingGene Expression Regulation, NeoplasticPrognosisMicrotubule-Associated Proteins

Stichwörter der Autor:innen

G2 and S phase‐expressed‐1immune infiltrationlung adenocarcinomapan‐cancerprognostic biomarkers

Substanzen

Biomarkers, TumorGTSE1 protein, humanMicrotubule-Associated Proteins

Autor:innen und Institutionen

  • Department of Cardio-Thoracic Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

ORCID-Profile: Guanqiang Yan, Jingxiao Li, Huafu Zhou

Förderung

  • Guangxi Medical And Health Key Discipline Construction Project
  • Guangxi Key Clinical Specialty Construction Project
  • National Key Clinical Specialty Construction Project

Zitieren

APA

Yan, G., Li, G., Gao, X., Liu, J., Li, Y., Li, J., & Zhou, H. (2024). GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma. The Clinical Respiratory Journal, 18(5). https://doi.org/10.1111/crj.13757

Vancouver

Yan G, Li G, Gao X, Liu J, Li Y, Li J, et al. GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma. The Clinical Respiratory Journal. 2024;18(5). doi:10.1111/crj.13757

BibTeX
@article{Yan2024,
  author = {Yan, Guanqiang and Li, Guosheng and Gao, Xiang and Liu, Jun and Li, Yue and Li, Jingxiao and Zhou, Huafu},
  title = {GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma},
  journal = {The Clinical Respiratory Journal},
  year = {2024},
  volume = {18},
  number = {5},
  doi = {10.1111/crj.13757}
}
Kostenlos starten →